Doxazosin
- Product NDC
- 71610-482
- 11-digit product format
- 716100482
- Labeler code
- 71610
- Product ID
- 71610-482_5d499a9f-8647-4ede-bb94-ad6f2302d14f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA209013
- Marketing category
- ANDA
- Marketing start
- 2018-04-17
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 86P6PQK0MU | DOXAZOSIN MESYLATE | 77883-43-3 | DOXAZOSIN MESYLATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-482-60 | 71610048260 | 90 TABLET in 1 BOTTLE (71610-482-60) | 90 tablet | 2020-11-10 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Doxazosin | Aphena Pharma Solutions - Tennessee, LLC | 2020-12-10 | HUMAN PRESCRIPTION DRUG LABEL | 1 |